Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Kira Q. Stolen"'
Autor:
Una J. Lee, Keith Xavier, Kevin Benson, Kimberly Burgess, Janet E. Harris-Hicks, Robert Simon, Jeffrey G Proctor, Katie C. Bittner, Kira Q Stolen, Chris P. Irwin, Sarah J. Offutt, Anne E. Miller, Elizabeth M. Michaud, Phillip C. Falkner, J. Chris Coetzee
Publikováno v:
Contemporary Clinical Trials Communications, Vol 35, Iss , Pp 101198- (2023)
Percutaneous tibial neuromodulation is a medical guideline recommended therapy for treating symptoms of overactive bladder. Stimulation is delivered to the tibial nerve via a thin needle placed percutaneously for 30 min once a week for 12-weeks, and
Externí odkaz:
https://doaj.org/article/00c73a2759614250b8bb945b8ef68556
Autor:
F. Roosevelt Gilliam, Renee M. Sullivan, Milan Seth, Kira Q. Stolen, Kellie Chase Berg, Brian Olshansky, Andrea M. Russo, Paul W. Jones
Publikováno v:
Europace. 16:668-673
Aims Implantable cardioverter-defibrillators (ICDs) treat ventricular tachycardia or fibrillation but may also deliver unnecessary shocks. We sought to determine if the frequency of ICD-detected non-sustained or diverted (NSD) episodes increases befo
Autor:
Renee M. Sullivan, John D. Day, Kira Q. Stolen, Milan Seth, Andrea M. Russo, Kellie Chase Berg, David L. Perschbacher, Brian Olshansky
Publikováno v:
Heart Rhythm. 9:351-358
Appropriate implantable cardioverter-defibrillator (ICD) therapy for ventricular tachycardia (VT) or ventricular fibrillation (VF) depends, in part, on the programming of tachycardia zones.We assessed events treated with ICD shocks or antitachycardia
Autor:
Michael Giudici, Stacia Merkel Kraus, F. Roosevelt Gilliam, Bruce L. Wilkoff, Guy E. Alvarez, Kellie Chase Berg, Bruce A. Koplan, Kira Q. Stolen, Donald L. Hopper, Andrew Benn
Publikováno v:
Journal of Cardiovascular Translational Research. 4:21-26
Rate-adaptive sensors are designed to restore a physiologic heart rate response to activity, in particular for patients that have chronotropic incompetence (CI). Limited data exist comparing two primary types of sensors; an accelerometer (XL) sensor
Autor:
Andrea M. Russo, Arthur Kendig, Christopher M. Mullin, Renee M. Sullivan, Brian Olshansky, John D. Day, Weiwei Li, Chirag M. Sandesara, Kira Q. Stolen
Publikováno v:
Journal of Cardiovascular Translational Research. 4:27-34
In patients with heart disease, diabetes and age predict adverse outcomes. It remains unclear whether persons with diabetes who have implantable cardioverter defibrillators (ICDs) have fewer appropriate and inappropriate ICD shocks. The objective of
Autor:
Brian Olshansky, Kira Q. Stolen, John D. Day, Andrea M. Russo, Darin L. Lerew, Christopher M. Mullin, Vinayak Doraiswamy
Publikováno v:
Journal of Cardiovascular Electrophysiology. 20:973-978
Introduction: Due to limited enrollment of women in previous trials, there is a paucity of data comparing outcome and arrhythmic events in men versus women with implantable cardioverter defibrillators (ICDs). Methods and Results: We analyzed outcome
Autor:
Pirjo Nuutila, K.E. Juhani Airaksinen, Kira Q. Stolen, Juhani Knuuti, Jukka Kemppainen, Jan Sundell, Tiina M. Salo, Heikki V. Huikuri, Timo H. Mäkikallio
Publikováno v:
Clinical Research in Cardiology. 98:725-730
Since altered heart rate (HR) fluctuations provide prognostic information in heart failure, we examined the associations between HR dynamics, myocardial efficiency and perfusion, among patients with dilated cardiomyopathy.Sixteen patients with dilate
Publikováno v:
Heart Rhythm. 6:2-8
Atrial fibrillation (AF) has been associated with higher rates of all-cause mortality in patients with heart failure (HF). The risk of newly detected AF in patients receiving implantable cardioverter-defibrillator (ICD) therapy is unknown.Newly detec
Publikováno v:
Heart Rhythm. 4:886-891
Background Excessive right ventricular (RV) pacing has been associated with adverse clinical outcomes in patients receiving pacemakers or implantable cardioverter-defibrillators (ICDs). It remains uncertain how much RV pacing is clinically deleteriou
Autor:
Helena Tuunanen, Kira Q. Stolen, Markku Laakso, Jarna C. Hannukainen, Juhani Knuuti, Petri Sipola, Keijo Peuhkurinen, Johanna Kuusisto, Päivi Marjamäki, Pertti Jääskeläinen, Tapio Viljanen, Jyri Toikka, Pirjo Nuutila
Publikováno v:
Journal of Nuclear Cardiology. 14:354-365
The relationship between myocardial metabolic changes and the severity of left ventricular (LV) hypertrophy in patients with hypertrophic cardiomyopathy (HCM) is largely unknown. We characterized metabolic abnormalities in patients with a genetically